Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Carvedilol for Acute Portal Pressure Reduction in Cirrhosis
NCT07108075Recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jun 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of metformin in Portal Hypertension (PH) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Hepatic Venous Pressure Gradient response at 2 hours. Started Jun 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT07108075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07108075.